• Mashup Score: 14

    Optimal patient selection for neoadjuvant chemotherapy prior to surgical extirpation is limited by the inaccuracy of contemporary clinical staging met…

    Tweet Tweets with this article
    • Our study is finally online @EUplatinum! https://t.co/V7z6XKH2gv… ▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on surgical specimen ▶️ctDNA prognostic of post-surgical outcomes Amazing collaboration with @FaltasLab @AndreaNecchi @JoshMeeks @predicine @MoffittGUOnc

    • RT @UrogerliMD: Our study is finally online @EUplatinum! https://t.co/V7z6XKH2gv… ▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on…

    • RT @UrogerliMD: Our study is finally online @EUplatinum! https://t.co/V7z6XKH2gv… ▶️Pre-op plasma ctDNA predicts muscle invasive #UTUC on…

  • Mashup Score: 0

    Firas Petros, Urologic Oncologist from the University of Toledo College of Medicine joins Sam Chang in reviewing practice-changing and hypothesis-generating abstracts from the upper tract urothelial carcinoma podium session at the 2022 Annual Meeting of the American Urological Association (AUA). Dr. Petros first highlights two abstracts that involved the use of circulating tumor DNA as a…

    Tweet Tweets with this article
    • Exploring exciting insights in #Urology! Firas Petros from @UToledoMed joins @UroCancerMD @VUMC_Cancer to discuss #CTDNA as a biomarker, photodynamic therapy for #UTUC, real-world data on chemoablation, and more > https://t.co/003Ji52bG8 https://t.co/IOBRzssvLj

  • Mashup Score: 0

    In the wake of being diagnosed with upper tract urothelial cancer (UTUC), patient Tom Murphy navigates through his treatment options, ultimately settling on JELMYTO® (mitomycin) treatment. This less invasive procedure consists of six weekly treatments which were, according to Murphy, relatively simple and unobtrusive to his everyday life. Expressing gratitude for the guidance and support of his…

    Tweet Tweets with this article
    • Choosing @jelmyto: A patient's journey through less invasive upper tract #UrothelialCarcinoma treatment. Tom Murphy guides us through his treatment options and decisions after his #UTUC diagnosis. #WatchNow on UroToday > https://t.co/F2w2TZm69t @UroGenPharma https://t.co/MtbZRaP5u0